Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PlenadrEMA study
2014-002039-32Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydrocortisone in Adrenocorticotropic hormone (2 arms), sponsored by Rigshospitalet. Primary endpoint: Diurnal variations of fatigue (EMA). Started Jul 2014; status: completed.
02
Drugs
hydrocortisone
03
Conditions
Adrenocorticotropic hormone
Beyond the preview
Go deeper on 2014-002039-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002039-32.